1. Home
  2. PXLW vs KALA Comparison

PXLW vs KALA Comparison

Compare PXLW & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PXLW
  • KALA
  • Stock Information
  • Founded
  • PXLW 1997
  • KALA 2009
  • Country
  • PXLW United States
  • KALA United States
  • Employees
  • PXLW N/A
  • KALA N/A
  • Industry
  • PXLW Semiconductors
  • KALA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PXLW Technology
  • KALA Health Care
  • Exchange
  • PXLW Nasdaq
  • KALA Nasdaq
  • Market Cap
  • PXLW 28.1M
  • KALA 26.2M
  • IPO Year
  • PXLW 2000
  • KALA 2017
  • Fundamental
  • Price
  • PXLW $7.99
  • KALA $5.87
  • Analyst Decision
  • PXLW Strong Buy
  • KALA Strong Buy
  • Analyst Count
  • PXLW 2
  • KALA 3
  • Target Price
  • PXLW $15.00
  • KALA $14.00
  • AVG Volume (30 Days)
  • PXLW 73.1K
  • KALA 125.3K
  • Earning Date
  • PXLW 08-06-2025
  • KALA 08-05-2025
  • Dividend Yield
  • PXLW N/A
  • KALA N/A
  • EPS Growth
  • PXLW N/A
  • KALA N/A
  • EPS
  • PXLW N/A
  • KALA N/A
  • Revenue
  • PXLW $34,246,000.00
  • KALA N/A
  • Revenue This Year
  • PXLW $5.21
  • KALA N/A
  • Revenue Next Year
  • PXLW $35.68
  • KALA N/A
  • P/E Ratio
  • PXLW N/A
  • KALA N/A
  • Revenue Growth
  • PXLW N/A
  • KALA N/A
  • 52 Week Low
  • PXLW $4.67
  • KALA $2.92
  • 52 Week High
  • PXLW $14.16
  • KALA $11.20
  • Technical
  • Relative Strength Index (RSI)
  • PXLW 60.10
  • KALA 60.68
  • Support Level
  • PXLW $6.71
  • KALA $4.36
  • Resistance Level
  • PXLW $7.67
  • KALA $7.00
  • Average True Range (ATR)
  • PXLW 0.52
  • KALA 0.71
  • MACD
  • PXLW 0.02
  • KALA 0.16
  • Stochastic Oscillator
  • PXLW 66.67
  • KALA 63.97

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: